Stay updated with breaking news from Physical Activity Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The international expert group behind the Severe Asthma Index calls on policymakers to take three urgent actions to tackle the disproportionate impact of severe asthma on patients and health systems.
UNION therapeutics’ COVID-19 candidates show promising results in phase 1 study Apr 7 2021 UNION therapeutics A/S (UNION) announced today that the results of a phase 1 study of inhaled and intranasal niclosamide (UNI911) have been published by The Lancet Regional Health – Europe (LINK). With no serious adverse effects reported, the study showed a strong safety profile of inhaled and intranasal niclosamide which was the primary endpoint for the trial. The promising safety and pharmacokinetic results for inhaled and intranasal niclosamide have opened the doors for further investigation, and...
UNION therapeutics' COVID-19 candidates found to be well tolerated in Phase 1 Lancet publication The Lancet Regional Health - Europe has published the results of UNION therapeutics' phase 1 study of inhaled and intranasal niclosamide products (UNI91103 and UNI91104) The study endpoints were to assess the safety profile and the pharmacokinetic profile of niclosamide when administered as a nasal spray and as an inhalation product (nebulizer) The study was placebo-controlled and conducted in healthy volunteers No adverse effects were identified, paving the way for further investigation in COVID-...